Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- MONDO_0001087 type Disease assertion.
- association type Statement assertion.
- DRUGBANK:DB01267 type Drug assertion.
- context type Cohort assertion.
- association label "Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved." assertion.
- context label "Adolescents (15-17)" assertion.
- association subject DRUGBANK:DB01267 assertion.
- association predicate treats assertion.
- association object MONDO_0001087 assertion.
- association has_population_context context assertion.
- association relation OffLabelIndication assertion.
- association publications 31096228 assertion.
- association provided_by NeuroDKG assertion.